SCHEMBL5361803

SCHEMBL5361803

O=C1Nc2ccc(CCCl)cc2C1=Cc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.65
MAOA P21397 2/20 0.51
MAOB P27338 2/20 0.51
PSEN1 P49768 2/20 0.51
PSEN2 P49810 2/20 0.51
APH1B Q8WW43 2/20 0.51
NCSTN Q92542 2/20 0.51
APH1A Q96BI3 2/20 0.51
PSENEN Q9NZ42 2/20 0.51
JAK3 P52333 1/20 0.49
RAF1 P04049 1/20 0.49
PDPK1 O15530 1/20 0.48
PLK4 O00444 2/20 0.47
PLK1 P53350 2/20 0.47
PIM1 P11309 1/20 0.47
RET P07949 1/20 0.47
FLT3 P36888 1/20 0.47
PDGFRB P09619 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7134346 0.93 RAF1 (0.57) LRRK2MAOAMAOBPSEN1PSEN2
SCHEMBL7135558 0.90 PSEN1 (0.55) LRRK2MAOAMAOBPSEN1PSEN2
SCHEMBL7136650 0.89 LRRK2 (0.61) LRRK2MAOAMAOBPSEN1PSEN2
SCHEMBL7140932 0.88 PSEN1 (0.62) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL7139020 0.88 PSEN1 (0.61) LRRK2MAOAMAOBPSEN1PSEN2
SCHEMBL7137564 0.87 PSEN1 (0.52) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL7133824 0.87 PSEN1 (0.52) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL7139535 0.87 LRRK2 (0.49) LRRK2MAOAMAOBPSEN1PSEN2
SCHEMBL7138836 0.86 MAOA (0.51) LRRK2MAOAMAOBPSEN1PSEN2
SCHEMBL7133366 0.85 NTRK1 (0.53) LRRK2PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK LRRK2 289/4885MAOA 1231/4885MAOB 867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.